期刊文献+

采供血质量记录的潜在问题分析与干预效果评估 被引量:1

A Study of Potential Problems and Intervention Effects on Quality Records of Blood Collection and Supply
下载PDF
导出
摘要 目的:了解采供血记录中的缺陷,分析原因,主动干预,以提高记录质量,提高员工法律认知、自我保护意识,降低或杜绝差错事故及医疗纠纷的发生。方法:2012年1至6月随机抽样5146份质量记录为对照组;2013年1至6月采取针对性的干预策略后随机抽样6348份质量记录为观察组。结果:采取针对性的干预策略后,记录缺陷数明显减低。结论:在采供血记录中加强法律、法规知识,加强技能培训和专业知识培训,建立全面质量管理体系,对保障输血安全、维护自身的利益具有法律意义。 Objective: To find out the defects in the records of blood collection,analyze the reasons,and intervene initiatively to improve the record quality; to arouse the awareness of the record law,strengthen the consciousness of self-protection,and eliminate the occurrence of accidents and medical malpractice. Methods: Random sampling of 5146 records from January to June in2012 was chosen as the control group,and random sampling of 6348 records from January to June in 2013,which were made after the targeted interventions,had been taken,was chosen as the observation group. Results: After adopting the measures of targeted interventions,the number of the defects in the records was reduced obviously. There were significant differences. Conclusion: It is vital to strengthen the awareness of the law in the records of blood collection,the skill training and professional knowledge training; to strengthen supervision,establish the total systems of quality management. It is of legal significance to ensure the safety of blood transfusion and protect the self-interest.
机构地区 顺德区中心血站
出处 《长江大学学报(自科版)(下旬)》 CAS 2014年第8期104-106,5,共3页 Journal of Yangtze University
关键词 采供血质量记录 问题 干预 评估 quality records potentioal problems intervention assessment
  • 相关文献

参考文献2

二级参考文献15

  • 1卫生部医政司WHO质量管理项目组.WHO输血服务机构质量管理项目培训在我国的实施及启示[J].中国输血杂志,2006,19(z1):53-55. 被引量:11
  • 2后平钦,洪鹰,彭继红,苗燕平,黄智君,李国良,罗强,肖湘莲.建立质量监督管理体系中的难点问题与对策研究[J].中国卫生质量管理,2004,11(3):59-60. 被引量:4
  • 3中华人民共和国卫生部.血站基本标准[S].卫医发[2000]448号,2000.
  • 4国家药品监督管理局.药品生产质量管理规范(1998年修订)[S].1999-08-01
  • 5Health Products and Food Branch.Human blood and blood components[S]//LPFB.Good manufacturing practices for schedule D drugs.Ottawa:LPFB,1999.
  • 6WHO.Requirements for the collection,processing and quality control of blood components and plasma derivatives (revised 1992)[S]// WHO.Technical report series No 840.Geneva:WHO,1994.
  • 7Therapeutic Goods Administration.The Australian code of good manufacturing practice-human blood and tissues[S].Canberra:TGA,2000.
  • 8陈啸宏.继续推进无偿献血,全面加强血液管理,努力开创我国血液管理工作的新局面.卫生政务通报,2006,5:1-12.
  • 9AABB.对于血液,我们还能做点什么:有关献血者资格判定的科学展望[M]//AABB.新千年血液安全.郭永建,译.上海:上海科学技术出版社,2005.1-28.
  • 10FDA.Guideline for quality assurance in blood establishment (1995)[S].Rockville:CBER Office of Communication,Training,and Manufacturer's Assistance,1995.

共引文献23

同被引文献5

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部